trkC agonist (Zebra Biologics)

N/A

Report date: 2025/03/20 09:36:04

Base Information

Drug NametrkC agonist (Zebra Biologics)
Drug Alias Nametropomysin receptor kinase C agonist (Zebra Biologics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 3 agonists
TargetsNeurotrophic tyrosine kinase receptor type 3
Therapy Area/IndicationsPeripheral Nervous System DiseasesCentral Nervous System DiseasesHearing Loss, Sensorineural
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZebra Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesZebra Biologics Inc
Inactive CompaniesN/A
Active IndicationsHearing Loss, Sensorineural
Inactive IndicationsPeripheral Nervous System DiseasesCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A